Newsroom

L’UBP a le plaisir d’annoncer être le nouveau partenaire de la Comédie de Genève pour les trois prochaines saisons.

Despite waning global growth momentum and rising inflation, strong fundamentals and relative valuations are offering compelling arguments for a strategic allocation to emerging market fixed income.

Global consumers’ everyday lives are shaped by Swiss products and services at different levels and in various aspects. Our experts dive into the secret behind “Swiss-made” quality.

Le Temps (27.12.2021) - Il est une perspective sur laquelle tout le monde s’accorde aujourd’hui: l’industrie financière est appelée à jouer un rôle majeur dans la décarbonisation des économies de par sa capacité à réorienter stratégiquement les flux de capitaux privés.

The surge in inflation in 2021 combined with the sharp fall in unemployment leaves two of the US Federal Reserve’s key policy objectives within reach as the year comes to a close.

L’UBP annonce avoir franchi une nouvelle étape dans son engagement en faveur de l’impact investing avec le lancement d’une stratégie centrée sur la restauration de la biodiversité. Cette solution d’investissement est le fruit d’une collaboration unique entre l’industrie financière, le secteur des entreprises, ainsi que des experts en préservation de la nature.

The global pandemic has allowed the European Union to lay a new foundation upon which it can build to bring about greater integration in the years ahead.

As part of Building Bridges Week – the agenda-setting event on sustainable finance taking place in Geneva from 29 November to 2 December 2021 – UBP hosted an interactive panel discussion on biodiversity and its investment opportunities.

The Swiss small- and mid-cap (also known as “SMID-cap”) universe offers a balanced and diversified exposure to companies with long-term value-creation potential. Active managers can create significant added value through a disciplined stock-selection process.

Funds People (17.11.2021) - The rise of passive management, the difficulty of finding profitable, low-risk investments in a context of 0% interest rates, industry concentration and the ESG boom are just some of the challenges asset managers face. We spoke to Nicolas Faller, Co-CEO of Asset Management at Union Bancaire Privée, about all of this and more, in an exclusive interview. 

In the latest episode of UBP’s Expert series, Norman Villamin, CIO Wealth Management and Pierre Corby, Equity Analyst Healthcare, invited Dr Samarth Kulkarni, CEO of CRISPR Therapeutics, to discuss the challenges and investment opportunities offered by medical innovation, specifically in the field of gene editing.

Embracing Change